Skip to Main Content

Paper Details

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI.
Sci Rep
9
2022
IDH, IDH mutation, IDH wild, IDH wild-type glioma, amine, glioma, gliomas, glucose, glucose transporter 3, hexokinase, human, hypoxia-inducible factor 1-alpha, isocitrate, isocitrate dehydrogenase, patients, tumor, tumors
Author NameAffiliation
Noriko SalamonDavid Geffen School of Medicine, University of California los angeles
Noriko SalamonDavid Geffen School of Medicine, University of California los angeles
Whitney B PopeDavid Geffen School of Medicine, University of California los angeles
Whitney B PopeDavid Geffen School of Medicine, University of California los angeles
Timothy F Cloughesyuniversity of california los angeles Neuro-Oncology Program, University of California
Timothy F CloughesyDavid Geffen School of Medicine, University of California Los Angeles
Timothy F Cloughesyuniversity of california los angeles Neuro-Oncology Program, University of California
Timothy F CloughesyDavid Geffen School of Medicine, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California
Benjamin M EllingsonDavid Geffen School of Medicine, University of California los angeles
Benjamin M EllingsonUniversity of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Neuro-Oncology Program, University of California
Benjamin M EllingsonDavid Geffen School of Medicine, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California
Benjamin M EllingsonDavid Geffen School of Medicine, University of California los angeles
Benjamin M EllingsonUniversity of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Neuro-Oncology Program, University of California
Benjamin M EllingsonDavid Geffen School of Medicine, University of California Los Angeles
  • 1 - 18

Datasets